An intern with the ChemNeuro group, Orvin Pierre, recently shared his journey towards medicine in the Harvard Gazette. In the interview with the Harvard junior, he reflects upon his innate desire to problem-solve, piecing together studies in science and humanism in preparation to be a physician.
Congratulations to Jacob Hooker, the academic founder of Eikonizo Therapeutics, for entering a collaboration agreement with the McQuade Center for Strategic Research and Development, to develop inhibitors of histone deacetylase-6 (HDAC6) focused on treating amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, and other diseases. The group is excited to have the resources needed to get […]
Changning Wang Wins Ken Griffin Alpha-synuclein Imaging Competition
Jacob Hooker Named a Distinguished Investigator by The Academy for Radiology & Biomedical Imaging Research
Home Team Research News Publications Opportunities Join ChemNeuro Participate Changning Wang Receives Alzheimer’s Drug Discovery Foundation Award Changning Wang received an award from Alzheimer’s Drug Discovery Foundation, under the Neuroimaging and CSF Biomarker Development Program. This funded project is to develop novel PET imaging probes for Receptor-interacting serine/threonine-protein kinase 1 (RIPK1). RIPK1 is a critical signaling protein in […]
Home Team Research News Publications Opportunities Join ChemNeuro Participate Nicole Zurcher Interviewed Regarding Low Protein Finding in Males with Autism Nicole Zurcher was interviewed by Boston 25 News about her findings of low translator protein in adult men with autism, which were recently published in Molecular Psychiatry. Her work was also featured in the Boston […]